TRUALT BIOENERGY LIMITED (TRUALT) financials
TRUALT BIOENERGY LIMITED (TRUALT) NSE/BSE financials on Fincrux: quarterly results, profit and loss, cash flow, balance sheet, ratios, and shareholding.
Incorporated in 2021, Trualt Bioenergy Limited is engaged in the production of biofuels, with a primary focus on the ethanol sector.[1]
- Market Cap: ₹3,713Cr.
- Current Price: ₹433
- Stock P/E: 26.0
- ROE: 7.02%
- ROCE: 9.89%
- Book Value: ₹176
- Dividend Yield: 0.00%
- 52W High / Low: ₹542/310
In Jun 2026, TRUALT BIOENERGY LIMITED (TRUALT) reported sales ₹616 Cr and net profit ₹55 Cr.
Annual TTM: sales ₹2,027 Cr, net profit ₹143 Cr.
Shareholding: Promoters 71.37% (Sep 2026), FIIs 0.62% (Sep 2026), DIIs 9.09% (Sep 2026), Public 18.91% (Sep 2026), No. of Shareholders 60,248% (Sep 2026).
| Category | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Sales | 382 | 407 | 899 | 294 | 104 | 703 | 603 | 616 |
| Expenses | 363 | 288 | 748 | 259 | 116 | 574 | 462 | 489 |
| Operating Profit | 19 | 119 | 151 | 35 | -12 | 129 | 142 | 127 |
| OPM % | 4.9% | 29% | 17% | 12% | -11% | 18% | 23% | 21% |
| Other Income | 16 | 16 | 14 | 23 | 15 | 18 | 13 | 14 |
| Interest | 33 | 35 | 38 | 37 | 38 | 40 | 43 | 44 |
| Depreciation | 16 | 17 | 17 | 20 | 20 | 21 | 22 | 24 |
| Profit before tax | -14 | 83 | 109 | 0 | -55 | 86 | 90 | 73 |
| Tax % | 17% | 13% | -1% | 79% | -23% | 23% | 28% | 25% |
| Net Profit | -17 | 72 | 110 | 0 | -43 | 66 | 65 | 55 |
| EPS in Rs | -2.39 | 10.25 | 15.61 | 0.00 | -4.99 | 7.70 | 7.54 | 6.41 |
| Raw PDF | — | — | — | — | — | — | — | — |
| Category | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|
| Sales | 0 | 762 | 1,217 | 1,880 | 1,705 | 2,027 |
| Expenses | 0 | 657 | 1,029 | 1,583 | 1,422 | 1,641 |
| Operating Profit | -0 | 105 | 188 | 297 | 283 | 385 |
| OPM % | — | 14% | 15% | 16% | 17% | 19% |
| Other Income | 0 | 0 | 56 | 61 | 68 | 60 |
| Interest | 0 | 35 | 141 | 141 | 158 | 164 |
| Depreciation | 0 | 21 | 56 | 65 | 84 | 88 |
| Profit before tax | -0 | 49 | 47 | 152 | 109 | 193 |
| Tax % | 0% | 28% | 27% | 8% | 27% | — |
| Net Profit | -0 | 35 | 35 | 141 | 80 | 143 |
| EPS in Rs | -1.64 | 5.81 | 5.67 | 19.91 | 9.33 | 16.66 |
| Dividend Payout % | 0% | 0% | 0% | 0% | 0% | — |
| Category | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Equity Capital | 0.06 | 61 | 61 | 71 | 86 |
| Reserves | -0 | 179 | 208 | 697 | 1,428 |
| Borrowings | 0 | 1,150 | 1,657 | 1,539 | 1,586 |
| Other Liabilities | 0 | 465 | 437 | 671 | 530 |
| Total Liabilities | 0 | 1,856 | 2,363 | 2,978 | 3,629 |
| Fixed Assets | 0 | 1,302 | 1,371 | 1,772 | 2,117 |
| CWIP | 0 | 10 | 201 | 3 | 23 |
| Investments | 0 | 0 | 27 | 21 | 49 |
| Other Assets | 0 | 545 | 764 | 1,182 | 1,440 |
| Total Assets | 0 | 1,856 | 2,363 | 2,978 | 3,629 |
| Category | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Cash from Operating Activity | 0 | 233 | 28 | 335 | -296 |
| Cash from Investing Activity | 0 | -1,149 | -389 | -257 | -358 |
| Cash from Financing Activity | 0 | 920 | 373 | 52 | 555 |
| Net Cash Flow | 0 | 5 | 13 | 130 | -100 |
| Free Cash Flow | 0 | -42 | -334 | 76 | -610 |
| CFO/EBITDA Share of operating profit converting into cash: CFO (before tax) / Operating Profit | 0% | 222% | 17% | 112% | -103% |
| Category | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|
| Promoters | 70.55% | 70.55% | 70.55% | 71.37% |
| FIIs | 0.93% | 0.66% | 0.57% | 0.62% |
| DIIs | 7.28% | 9.40% | 8.36% | 9.09% |
| Public | 21.26% | 19.38% | 20.51% | 18.91% |
| No. of Shareholders | 80,013 | 73,790 | 62,478 | 60,248 |
| Category | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Debtor Days | — | 41 | 89 | 66 | 87 |
| Inventory Days | — | 112 | 71 | 59 | 172 |
| Days Payable | — | 225 | 63 | 135 | 89 |
| Cash Conversion Cycle | — | -72 | 97 | -10 | 170 |
| Working Capital Days | — | 8 | -126 | -25 | 63 |
| ROCE % | — | 12% | 11% | 14% | 10% |
Trualt Bioenergy Limited
₹3,713Cr.
₹433
₹542/310
26.0
Incorporated in 2021, Trualt Bioenergy Limited is engaged in the production of biofuels, with a primary focus on the ethanol sector.[1]
Quarterly results
Profit & loss
Shareholding trend
Balance sheet
Cash flows
Key ratios
Frequently asked questions
What is the market cap of TRUALT BIOENERGY LIMITED (TRUALT)?
The reported market capitalisation for TRUALT BIOENERGY LIMITED (TRUALT) is ₹3,713Cr. on Fincrux. Figures may update with market data and filings.
What is the current share price of TRUALT?
The current price shown for TRUALT BIOENERGY LIMITED (TRUALT) on Fincrux is ₹433 with a 52-week high/low of ₹542/310.
What is the P/E ratio of TRUALT BIOENERGY LIMITED (TRUALT)?
The stock P/E for TRUALT BIOENERGY LIMITED (TRUALT) is 26.0 on Fincrux, with ROE at 7.02% and ROCE at 9.89%.
What were TRUALT latest quarterly results?
For Jun 2026, TRUALT BIOENERGY LIMITED (TRUALT) reported sales ₹616 Cr and net profit ₹55 Cr (figures in ₹ crore unless noted).
What are TRUALT annual sales and net profit?
For TTM, TRUALT BIOENERGY LIMITED (TRUALT) shows sales of ₹2,027 Cr and net profit of ₹143 Cr on the Fincrux profit & loss statement.
Who owns TRUALT BIOENERGY LIMITED (TRUALT)?
Latest shareholding for TRUALT BIOENERGY LIMITED (TRUALT) on Fincrux: Promoters 71.37% (Sep 2026), FIIs 0.62% (Sep 2026), DIIs 9.09% (Sep 2026), Public 18.91% (Sep 2026), No. of Shareholders 60,248% (Sep 2026).
Where can I find TRUALT BIOENERGY LIMITED (TRUALT) financials?
TRUALT BIOENERGY LIMITED (TRUALT) financials on Fincrux include quarterly results, profit and loss, cash flow, balance sheet, key ratios, and shareholding patterns for NSE/BSE research.
Does Fincrux show TRUALT balance sheet and cash flow?
Yes. The TRUALT BIOENERGY LIMITED (TRUALT) page on Fincrux includes balance sheet, cash flow statements, historical ratios, and ownership trends alongside quarterly and annual results.